Cancer Therapy News and Research

RSS

Traveling to academic medical center for surgical removal of pancreatic cancer linked to longer survival

New study findings link traveling to an academic medical center for surgical removal of pancreatic or thyroid cancer with higher quality surgical care for both cancers, and longer survival for patients with pancreatic cancer compared with patients who receive treatment at a hospital closer to home.

2 May 2017

Aspirin used in “baby” doses may prevent breast cancer, study suggests

A new study led by City of Hope researchers has found that regular use of low-dose aspirin (81mg) reduces breast cancer risk in women. Led by Leslie Bernstein, the team found that women who took the low-dose aspirin, also known as “baby” aspirin, at least three times per week had an overall 16% reduced risk of developing breast cancer.

2 May 2017

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

Surgery and radiation remove, kill, or damage cancer cells in a certain area. But chemotherapy -- which uses medicines or drugs to treat cancer -- can work throughout the whole body, killing cancer cells that have spread far from the original tumor.

2 May 2017

Combination therapy may be effective option for treating some women with ovarian cancer

Researchers have been trying to understand why up to 85 percent of women experience recurrence of high-grade serous ovarian cancer -- the most common subtype of ovarian cancer -- after standard treatment with the chemotherapy drug carboplatin.

2 May 2017

UH-led researchers focus on creating durable T cells to make immunotherapy more effective

Immunotherapy, in which cells from the human immune system are unleashed to fight disease, has been the big story in cancer treatment over the past few years. When it works, it can spur long-lasting remission in patients for whom other treatments have failed.

2 May 2017

Study: New gene editing strategy effectively targets cancer-causing ‘fusion genes’ in mouse models

A novel gene therapy using CRISPR genome editing technology effectively targets cancer-causing "fusion genes" and improves survival in mouse models of aggressive liver and prostate cancers, University of Pittsburgh School of Medicine researchers report in a study published online today in Nature Biotechnology.

2 May 2017

Noninvasive PET imaging may predict cancer patients’ immunotherapy response early

A noninvasive PET imaging method that measures granzyme B, a protein released by immune cells to kill cancer cells, was able to distinguish mouse and human tumors that responded to immune checkpoint inhibitors from those that did not respond early in the course of treatment.

1 May 2017

MDI Biological Laboratory investigator awarded NIH grant for research on peripheral neuropathy

The MDI Biological Laboratory has announced that Sandra Rieger, Ph.D., has been awarded a highly competitive grant from the National Cancer Institute, an institute of the National Institutes of Health, to study the molecular mechanisms underlying chemotherapy-induced peripheral neuropathy, a side effect of cancer chemotherapy causing symptoms such as pain, tingling, temperature sensitivity and numbness in the extremities.

29 Apr 2017

Takeda announces accelerated approval from FDA for new lung cancer treatment

Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that ALUNBRIG (brigatinib) has received Accelerated Approval from the U.S. Food and Drug Administration for the treatment of patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer who have progressed on or are intolerant to crizotinib.

28 Apr 2017

Research shows how TET2 protein loss can open door for mutations that drive blood cancers

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the original motorist - the one who caused the problem - drives on.

25 Apr 2017

Mayo Clinic study shows surgery could more than double life expectancy for kidney cancer patients

Mayo Clinic researchers have discovered that surgery could more than double life expectancy for many patients with late-stage kidney cancer, giving them anywhere from two to almost 10 years more than they'd have without the surgery.

25 Apr 2017

New findings support use of integrative therapies for treating breast cancer patients

In newly updated clinical guidelines from the Society for Integrative Oncology, researchers at Columbia University's Mailman School of Public Health and the Herbert Irving Comprehensive Cancer Center with an interdisciplinary team of colleagues at MD Anderson Cancer Center, University of Michigan, Memorial Sloan Kettering Cancer Center, and other institutions in the U.S. and Canada, analyzed which integrative treatments are most effective and safe for patients with breast cancer.

24 Apr 2017

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Researchers from UT Southwestern Medical Center have developed a first-of-its-kind nanoparticle vaccine immunotherapy that targets several different cancer types.

24 Apr 2017

Study offers better understanding of progression of metastatic breast cancer

Researchers at the Jules Bordet Institute - Université libre de Bruxelles, VIB and KU Leuven published this 21 of April an important study offering a better understanding of the progression of breast cancer.

24 Apr 2017

New technique can test effectiveness of treatments for breast cancer metastases in bone

A new laboratory technique developed by researchers at Baylor College of Medicine and other institutions can rapidly test the effectiveness of treatments for life-threatening breast cancer metastases in bone. The study appears in Nature Communications.

21 Apr 2017

Second cancers are far deadlier in younger people than older adults

Second cancers in children and adolescents and young adults are far deadlier than they are in older adults and may partially account for the relatively poor outcomes of cancer patients ages 15-39 overall, a new study by UC Davis researchers has found.

20 Apr 2017

Quality of life for prostate cancer patients varies by type of treatment, study reveals

Quality of life after prostate cancer treatment varies by the type of treatment patients receive, a new study reveals.

20 Apr 2017

Drug created from malaria protein offers hope for bladder cancer patients

A drug created from a malaria protein stopped tumor growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

20 Apr 2017

IRCM researchers discover how immunotherapy works in some cancer patients

What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy.

19 Apr 2017

Addressing unmet needs in prostate cancer

Prostate cancer is the second most diagnosed cancer globally with over a million men diagnosed worldwide. We are fortunate in that better diagnostic techniques and better awareness means that men are often being diagnosed earlier, which gives them a better chance of being cured.

19 Apr 2017

Cancer Therapy News and Research

Traveling to academic medical center for surgical removal of pancreatic cancer linked to longer survival

Aspirin used in “baby” doses may prevent breast cancer, study suggests

TACC's supercomputers assist in discovery of new, better chemotherapy drugs

Combination therapy may be effective option for treating some women with ovarian cancer

UH-led researchers focus on creating durable T cells to make immunotherapy more effective

Study: New gene editing strategy effectively targets cancer-causing ‘fusion genes’ in mouse models

Noninvasive PET imaging may predict cancer patients’ immunotherapy response early

MDI Biological Laboratory investigator awarded NIH grant for research on peripheral neuropathy

Takeda announces accelerated approval from FDA for new lung cancer treatment

Research shows how TET2 protein loss can open door for mutations that drive blood cancers

Mayo Clinic study shows surgery could more than double life expectancy for kidney cancer patients

New findings support use of integrative therapies for treating breast cancer patients

UTSW researchers develop new nanoparticle vaccine immunotherapy that targets multiple tumor types

Study offers better understanding of progression of metastatic breast cancer

New technique can test effectiveness of treatments for breast cancer metastases in bone

Second cancers are far deadlier in younger people than older adults

Quality of life for prostate cancer patients varies by type of treatment, study reveals

Drug created from malaria protein offers hope for bladder cancer patients

IRCM researchers discover how immunotherapy works in some cancer patients

Addressing unmet needs in prostate cancer

Event guide: 7th Allogeneic Cell Therapies Summit eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News